Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-016637
Filing Date
2016-05-24
Accepted
2016-05-24 09:30:19
Documents
1
Period of Report
2016-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146409660579884.html 4  
1 FORM 4 wf-form4_146409660579884.xml 4 5439
  Complete submission text file 0001628280-16-016637.txt   6807
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Taglietti Marco (Reporting) CIK: 0001408870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 161670882